Dr. Anichtchik was born in Novogrudok, Belarus. He completed his medical education at Grodno State Medical University, Belarus in 1996, and received his PhD in 2001 from Abo Akademi University, Turku, Finland for characterization of central histaminergic nervous system in Parkinson’s disease (PD). He was then selected for Finnish Academy of Sciences postdoctoral fellowship to study neurotoxin-induced model of PD in zebrafish. He has continued to work on neurotoxic aspects of the zebrafish PD model in the biotechnology company Daniolabs Ltd (Cambridge, United Kingdom), where he became interested in mechanisms of protein aggregation and cell death in PD. Dr. Anichtchik continued in this vein after joining Prof. Maria Grazia Spillantini’s group, were he characterized transgenic pre-clinical models of alpha-synuclein aggregation. He has been Alzheimer Research UK Senior Research Fellow since 2010, studying the mechanisms and consequences of alpha-synuclein aggregation in the forebrain.